ロード中...

Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

Neprilysin is a widely expressed peptidase with broad substrate specificity that preferentially hydrolyses oligopeptide substrates, many of which regulate the cardiovascular, nervous and immune systems. Emerging evidence suggests that neprilysin also hydrolyses peptides that play an important role i...

詳細記述

保存先:
書誌詳細
出版年:Diabetologia
主要な著者: Esser, Nathalie, Zraika, Sakeneh
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6579747/
https://ncbi.nlm.nih.gov/pubmed/31089754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-019-4889-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!